Ticagrelor Generis Phar

Ticagrelor Generis Phar is an oral antiplatelet medication used to prevent blood clots after heart-related events. It belongs to the P2Y12 inhibitor class and supports cardiovascular health. This generic version is manufactured in the EU for oral use. Suitable for adults with specific heart conditions.

Ticagrelor is primarily used to reduce the risk of heart attack or stroke in people with a history of heart problems, such as those who have had a heart attack or undergone stent placement. It works by preventing blood platelets from clumping together, which can block arteries. This medication is often prescribed alongside low-dose aspirin for enhanced effectiveness in preventing blood clots. It is not a pain reliever but supports long-term heart health.

Ticagrelor may cause mild effects like shortness of breath, dizziness, or bruising more easily than usual. Some users report fatigue or mild headaches, which are generally temporary. It does not provide immediate pain relief but works gradually to support cardiovascular function. Staying hydrated and following a balanced diet may help minimize discomfort.

Keep this medication out of reach of children and store it at room temperature in a dry place. Avoid crushing or splitting tablets unless advised by a healthcare professional. Inform your doctor if you have bleeding disorders or liver problems before starting ticagrelor. Regular check-ups may be recommended to monitor its effects on your blood and heart.

Ticagrelor can interact with other medications that affect blood clotting, such as warfarin or NSAIDs like ibuprofen. Avoid grapefruit juice, as it may increase the risk of side effects. Alcohol consumption should be limited, as it can enhance dizziness or bleeding risks. Always inform your healthcare provider about all medications and supplements you are taking.